Companies / Argentina
Argentina's Roemmers Expects Drug Price Rises
March 2006 | Company Finance AlertLeading Argentine drugmaker Roemmers - which claims a 9% share of the country's US$2bn drug market - expects local firms to raise prices in the coming months. The comments come amid a new 60-day price freeze agreed between the government and the industry at the start of March
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
